Author

Danielle Tseng

University of Pittsburgh

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Assay:proteomics· 1

Frequent Co-Authors

Adrian V. LeeiD· 2 shared Steffi OesterreichiD· 2 shared Alexander Chih-Chieh ChangiD· 1 shared Clive S. D’SantosiD· 1 shared Daniel D. BrowniD· 1 shared Donald Patrick McDonnelliD· 1 shared Fangyuan CheniD· 1 shared Fazal HadiiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Adrian V. LeeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Dual HER2/HER3 Targeting with Antibody-Drug Conjugates Reveals a Novel Therapeutic Strategy for HER2-Mutant Lobular Breast Cancer

Jie Bin Liu, Ye Cao, Alexander Chih-Chieh Chang, Ryan Jaehne, Daniel D. Brown, Hunter Waltermire, Danielle Tseng, Rinath M. Jeselsohn, Guilherme Nader Marta, Jagmohan Hooda, Julia Foldi, Marija Balić, Adrian V. Lee, Steffi Oesterreich

This study shows HER2 mutations drive HER2/HER3 hyperactivation in ILC, making it sensitive to HER2/HER3-targeting ADCs, and highlights the synergy between T-DXd and P-DXd.

bioRxiv · Jun 19, 2026 · PreprintCancer Biology

EstroGene2.0: A multi-omic database of response to estrogens, ER-modulators, and resistance to endocrine therapies in breast cancer

Zheqi Li, Fangyuan Chen, Li Chen, Jiebin Liu, Danielle Tseng, Fazal Hadi, Soleilmane Omarjee, Kamal Kishore, Joshua Kent, Joanna M Kirkpatrick, Clive S. D’Santos, Mandy Lawson, Jason Gertz, Matthew J. Sikora, Donald Patrick McDonnell, , Adrian V. Lee

EstroGene2.0 is a multi-omic database that compiles data on estrogen receptor responses and resistance in breast cancer, revealing diverse transcriptomic changes and identifying key targets.

npj Breast Cancer · Dec 19, 2024Peer-reviewedCancer Biology